- Organizations: Boehringer Ingelheim
Pipeline
Boehringer partners with Re-Vana on extended-release ophthalmic therapeutics
Collaboration involves photo-crosslinked, biodegradable implants designed to enable continuous, 3-to-12-month drug delivery to treat retinal diseases.Products
Zeiss debuts new research data platform for integrated workflows
Company’s cloud-based solution uses AI technology to integrate accessible clinical and research data into clinicians’ daily routines.Business
Zeiss and Boehringer Ingelheim partner on early detection, prevention of retinal diseases
Collaboration will incorporate the ZEISS Medical Ecosystem with AI to detect early-stage diseases.Research